Ind-Swift Laboratories (BOM:532305) FFO


BOM:532305 Ind-Swift Laboratories Ltd BOM:532305
53 GF Score
Price ₹221.70
GF Value ₹36.98
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ind-Swift Laboratories FFO?

FFO (Funds from operations) only applies to REITs.

BOM:532305
53GF Score
Ind-Swift Laboratories Ltd BOM:532305
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ind-Swift Laboratories (BOM:532305) Overvalued in 2026?

Based on GuruFocus' analysis, Ind-Swift Laboratories stock appears to be overvalued. The current stock price of ₹221.70 is trading 499.5% above its estimated GF Value™ of ₹36.98. GuruFocus considers Ind-Swift Laboratories to be Significantly Overvalued.

Key valuation signals for BOM:532305:

  • FFO:
  • GF Value™: ₹36.98 vs. price of ₹221.70 (499.5% above fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the BOM:532305 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ind-Swift Laboratories Business Description

Other Exchanges INDSWFTLAB:India
Address SCO 850, NAC, Shivalik Enclave, Manimajra, Chandigarh, PB, IND, 160101
Ind-Swift Laboratories Ltd is involved in manufacturing Active Pharmaceutical Ingredients (API), Intermediates, and formulations. The company serves various therapeutic segments, including Cardiovascular health, Antihistamines, Antidiabetics, Antipsychotics, Parkinson's disease, Antineoplastics, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitors. It operates solely in the pharmaceutical products sector. Geographically, the company supplies both domestic and international markets, with the majority of its revenue coming from outside India.
53GF Score

Get the complete analysis for BOM:532305

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹221.70
Price
₹36.98
GF Value